Literature DB >> 31772382

Positive predictive value of optic disc haemorrhages for open angle glaucoma.

Brian Hogan1, Chris Trew1, Roxanne Annoh1, Cheng Yi Loo1, Huai Ling Tan1, Ling Shan Tang1, Andrew J Tatham2.   

Abstract

OBJECTIVES: To determine the positive predictive value (PPV) of disc haemorrhages (DHs) for the diagnosis of open angle glaucoma (OAG).
METHODS: A retrospective review of 618 consecutive new referrals by community optometrists to a hospital glaucoma service, including 54 patients with DHs. All patients had a comprehensive eye examination. The primary outcome was whether the patient was diagnosed with OAG in either eye, with a secondary outcome of whether they were discharged at the first visit (first visit discharge rate, FVDR).
RESULTS: 54 of 618 patients (8.7%) had a DH noted at the time of referral, including 21 referred with DH alone. 29 patients with DHs were diagnosed with OAG for a PPV of 54% (95% CI 40-67%), falling to 24% (95% CI 8-47%) in those with DH alone. The overall FVDR was 35%, increasing to 57% in those referred due to DH alone. The FVDR for those referred with DH alone was significantly higher than the FDVR of 25% among the 564 patients referred with suspected glaucoma without a DH (P = 0.001). The FVDR decreased to 35% for patients with a DH plus one other feature of glaucoma and to 0% for patients with a DH and at least two other features suggestive of glaucoma.
CONCLUSIONS: Almost 60% of patients referred due to isolated DHs were discharged at the first visit to the glaucoma clinic, however almost one in four was diagnosed with OAG. Patients with DH and other features suggestive of glaucoma had a higher probability of glaucoma diagnosis.

Entities:  

Mesh:

Year:  2019        PMID: 31772382      PMCID: PMC7784928          DOI: 10.1038/s41433-019-0711-9

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  1 in total

1.  Morphologic predictive factors for development of optic disc hemorrhages in glaucoma.

Authors:  Jost B Jonas; Peter Martus; Wido M Budde; Jochen Hayler
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-09       Impact factor: 4.799

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.